乳がんにおける潜在的な腫瘍抑制剤としてのコラーゲン型VIα鎖の役割:免疫調節の視点
Jian-Di Li1, Li-Li Deng2, Jia-Yuan Luo1
1Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Shuangyong Road 6, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
BMC cancer
|August 22, 2025
まとめ
コラーゲンVI型アルファ6鎖 (COL6A6) は乳がんにおいてダウンレギュレーションされ,腫瘍抑制剤として作用する. COL6A6を治療標的として示唆する,減少した発現は,不良の予後と変化した免疫微環境と相関する.
科学分野:
- 腫瘍学
- 免疫学
- 分子生物学
背景:
- コラーゲンVI型アルファ6鎖 (COL6A6) は,腫瘍抑制作用があると考えられる基礎膜の成分である.
- 乳がんの進行と腫瘍の免疫マイクロ環境におけるその機能は,大部分は特徴づけられていない.
研究 の 目的:
- 乳がんにおける COL6A6 発現パターンの調査
- COL6A6の腫瘍免疫微環境と患者の予後に対する影響を評価する.
- 乳がんにおける COL6A6 の役割の基礎となる分子メカニズムを解明する.
主な方法:
- 乳がん組織と対照群の免疫ヒストケミストリー
- グローバル遺伝子発現データセットの分析 (マイクロアレイ,シーケンシング,単細胞RNA-seq)
- 生存率分析と決定曲線分析を用いた予測評価
- 腫瘍解体 遺伝子セットの濃縮 スペーストランスクリプトミクス
- マウスモデルと転写調節分析
- COL6A6を標的とする治療薬のインシリコ予測
主要な成果:
- COL6A6の発現は,正常な組織と比較して,乳がん組織において有意に低かった.
- COL6A6のダウンレギュレーションは,全生存率と再発率の低下と相関する.
- COL6A6発現の減少は,筋膜および免疫細胞の浸透の増加と関連していたが,腫瘍の純度が低下した.
- COL6A6の低下は,免疫経路の変化と免疫細胞の浸透の減少に関連しており,潜在的にCBX2によって調節されている.
- MK-886は,COL6A6を標的とする潜在的な治療薬として特定されました.
結論:
- COL6A6は乳がんにおける腫瘍抑制剤として機能する.
- COL6A6の発現は,腫瘍の微小環境内の免疫活動と密接に関連しています.
- COL6A6は乳がんの潜在的予後バイオマーカーであり,治療目標である.
関連する概念動画
Fibril-associated Collagen
2.7K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Type IV Collagen of Basal Lamina
2.4K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
A type IV collagen molecule has six alpha chains which can...
2.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K


